Arctic Bioscience AS (OSL:ABS)
Norway · Delayed Price · Currency is NOK 3.650
-0.500 (-12.05%)
Sep 12, 2025, 2:40 PM CET
Arctic Bioscience AS Market Cap
Arctic Bioscience AS has a market cap or net worth of 101.26 million as of September 12, 2025. Its market cap has decreased by -72.28% in one year.
Market Cap
101.26M
Enterprise Value
153.93M
Revenue
45.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.65
Market Cap Chart
Since February 24, 2021, Arctic Bioscience AS's market cap has decreased from 668.24M to 101.26M, a decrease of -84.85%. That is a compound annual growth rate of -33.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 101.26M | 118.11% |
| Dec 30, 2024 | 46.43M | -82.57% |
| Dec 29, 2023 | 266.38M | -7.39% |
| Dec 30, 2022 | 287.63M | -33.50% |
| Dec 30, 2021 | 432.53M | -35.27% |
| Feb 24, 2021 | 668.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.46B |
| Nordhealth AS | 2.78B |
| Photocure ASA | 1.63B |
| ArcticZymes Technologies ASA | 1.43B |
| Thor Medical ASA | 1.36B |
| Vistin Pharma ASA | 1.02B |
| Omda AS | 990.52M |
| Gentian Diagnostics ASA | 854.40M |